杭州浙大迪迅生物基因工程有限公司

　　原标题：过敏性疾病的微生物组学：目前的认识和今后的机遇：美国过敏、哮喘和免疫学会和欧洲过敏与临床免疫学会2017PRACTALL文件
　　PRACTALL是由美国过敏、哮喘与免疫学会(American Academy of Allergy, Asthma & Immunology)和欧洲过敏与临床免疫学会(European Academy of Allergy and Clinical Immunology)联合发起的，旨在就过敏症与免疫学领域的前沿课题提供基于证据的共同建议。PRACTALL 2017侧重于研究已证实的微生物在哮喘、特应性皮炎和食物过敏患者中的作用。通过概述有关其在变应性疾病中的作用的重要知识空白以及填补这些空白所必需的策略。此外，还将对处置微生物组的方法上的进展进行回顾，确定哪些是有效的，哪些是无效的，以及作为将来干预过敏性疾病形成、进展或两者的基础。


　　延伸阅读


JACI
The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical  Immunology
https://doi.org/10.1016/j.jaci.2017.02.007
Abstract:
PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and immunology. PRACTALL 2017 is focused on what has been established regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allergy. This is complemented by outlining important knowledge gaps regarding its role in allergic disease and delineating strategies necessary to fill these gaps. In addition, a review of progress in approaches used to manipulate the microbiome will be addressed, identifying what has and has not worked to serve as a baseline for future directions to intervene in allergic disease development, progression, or both.
First Author:
Yvonne J.Huang
Correspondence:
Thomas A.Fleisher
All Authors:
YvonneJ.HuangMDaBenjaminJ.MarslandPhDbSupindaBunyavanichMD,MPH,MPhilcLiamO'MahonyPhDdDonald Y.M.LeungMD, PhDeAntonellaMuraroMD, PhDfMDg
Joseph HernandezMD, PhD ∗Scott D.BoydMD, PhD Stephen J.Galli MD   
　　创建过敏性疾病的科研、科普知识交流平台，为过敏患者提供专业诊断、治疗、预防的共享平台。